Chandra Bhagat Pharma Ltd
BSE:542934
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
35
67
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
C
|
Chandra Bhagat Pharma Ltd
BSE:542934
|
309.3m INR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
102.3B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
67.7B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
67.7B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.5B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.2B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.6B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66B HKD |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Chandra Bhagat Pharma Ltd
Glance View
Chandra Bhagat Pharma Ltd. engages in the business of marketing pharmaceutical critical care & health care products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2020-02-14. The firm is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. The company is also engaged in the business of marketing pharmaceutical critical care & health care products. The company offers a wide range of product portfolio of pharmaceutical formulation including intravenous (IV) & intramuscular (IM) range injections, and a few tablets to cater the domestic & export market. The company has established presence in major therapeutic categories for formulations such as anticancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology etc. The company is engaged in promoting and marketing of active pharmaceuticals ingredients (API's) in India.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Chandra Bhagat Pharma Ltd is -2.3%, which is below its 3-year median of -1.2%.
Over the last 3 years, Chandra Bhagat Pharma Ltd’s Operating Margin has decreased from 2.8% to -2.3%. During this period, it reached a low of -3.4% on Mar 31, 2024 and a high of 2.8% on Mar 3, 2022.